These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 30560750)

  • 1. Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients.
    Ebdrup BH; Axelsen MC; Bak N; Fagerlund B; Oranje B; Raghava JM; Nielsen MØ; Rostrup E; Hansen LK; Glenthøj BY
    Psychol Med; 2019 Dec; 49(16):2754-2763. PubMed ID: 30560750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
    Bak N; Ebdrup BH; Oranje B; Fagerlund B; Jensen MH; Düring SW; Nielsen MØ; Glenthøj BY; Hansen LK
    Transl Psychiatry; 2017 Apr; 7(4):e1087. PubMed ID: 28398342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data.
    Ambrosen KS; Skjerbæk MW; Foldager J; Axelsen MC; Bak N; Arvastson L; Christensen SR; Johansen LB; Raghava JM; Oranje B; Rostrup E; Nielsen MØ; Osler M; Fagerlund B; Pantelis C; Kinon BJ; Glenthøj BY; Hansen LK; Ebdrup BH
    Transl Psychiatry; 2020 Aug; 10(1):276. PubMed ID: 32778656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.
    Zarogianni E; Storkey AJ; Johnstone EC; Owens DG; Lawrie SM
    Schizophr Res; 2017 Mar; 181():6-12. PubMed ID: 27613509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of antipsychotic-naïve patients with schizophrenia based on functional connectivity from resting-state electroencephalography.
    Ambrosen KS; Fredriksson F; Anhøj S; Bak N; van Dellen E; Dominicus L; Lemvigh CK; Sørensen ME; Nielsen MØ; Bojesen KB; Fagerlund B; Glenthøj BY; Oranje B; Hansen LK; Ebdrup BH
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1785-1796. PubMed ID: 36729135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.
    Hill SK; Beers SR; Kmiec JA; Keshavan MS; Sweeney JA
    Schizophr Res; 2004 Jun; 68(2-3):127-36. PubMed ID: 15099597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomical pattern classification in a population-based sample of first-episode schizophrenia.
    Zanetti MV; Schaufelberger MS; Doshi J; Ou Y; Ferreira LK; Menezes PR; Scazufca M; Davatzikos C; Busatto GF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():116-25. PubMed ID: 23261522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between cognition and white matter microstructure in first-episode antipsychotic-naïve patients with schizophrenia and healthy controls: A multivariate pattern analysis.
    Thomas MB; Raghava JM; Pantelis C; Rostrup E; Nielsen MØ; Jensen MH; Glenthøj BY; Mandl RCW; Ebdrup BH; Fagerlund B
    Cortex; 2021 Jun; 139():282-297. PubMed ID: 33933719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia.
    Barch DM; Carter CS; Braver TS; Sabb FW; MacDonald A; Noll DC; Cohen JD
    Arch Gen Psychiatry; 2001 Mar; 58(3):280-8. PubMed ID: 11231835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal classification of drug-naïve first-episode schizophrenia combining anatomical, diffusion and resting state functional resonance imaging.
    Zhuang H; Liu R; Wu C; Meng Z; Wang D; Liu D; Liu M; Li Y
    Neurosci Lett; 2019 Jul; 705():87-93. PubMed ID: 31022433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.